Featured Research

from universities, journals, and other organizations

Genetic Mutation Protects Against Both HIV And Plague? Not So, Say Scientists At Scripps Research

Date:
February 12, 2004
Source:
Scripps Research Institute
Summary:
A group of scientists at The Scripps Research Institute have provided strong evidence that a popular hypothesis concerning the origins of a genetic mutation common among Caucasians of Northern European descent that protects against human immunodeficiency virus (HIV) is wrong.

La Jolla, CA, February 11, 2004 -- A group of scientists at The Scripps Research Institute have provided strong evidence that a popular hypothesis concerning the origins of a genetic mutation common among Caucasians of Northern European descent that protects against human immunodeficiency virus (HIV) is wrong.

Related Articles


The hypothesis suggests that the mutation conferred resistance against bubonic plague in the Middle Ages, much as it does against HIV today. This idea was based on the fact that the mutation first appeared around the same time that the "Black Death" plague epidemic killed a third of Europe's population in the years 1346–1352. Since HIV was not present in Europe at this time, individuals with the mutation must have been protected against some other disease.

In a brief communication to be published this week in the journal Nature, Scripps Research Immunology Professor Donald Mosier and his colleagues show this hypothesis to be incorrect.

Mosier performed studies that demonstrate that the mutation does not protect against plague infection in mouse models and that it is unlikely to have offered any protection against the plague in humans during the Middle Ages.

An Important Receptor

The mutation in question is in the C–C chemokine receptor 5 gene, which makes the human receptor protein called CCR5. CCR5 is a seven trans-membrane spanning protein of 332 amino acids that inserts into the cell membranes of human CD4+ T helper cells. HIV particles use CCR5 to gain entry into CD4+ T cells.

The CCR5 Δ32 mutation—a deletion of 32 bases of DNA from the CCR5 gene—was first identified in 1996 in individuals who seemed to be protected from infection with HIV despite having had multiple high-risk exposures to the virus.

The resistant individuals all had the 32-base pair mutation in their CCR5 genes, and that left them with CD4+ T cells with no CCR5 receptors, conferring resistance to HIV infection. Later data showed that individuals

who were heterozygous for the mutation had lower CCR5 expression levels, less cell-to-cell infection, and brighter clinical prognoses.

In order to test the HIV–plague hypothesis, an attenuated, non-transmissible form of Yersinia pestis, the bacterial cause of plague, was tested on mice both with and without the CCR5 Δ32 mutation. There was no difference in susceptibility between the two groups, says Mosier.

The possibility still exists, says Mosier, that the CCR5 Δ32 mutation arose due to the influence of some other disease that was prevalent in the Middle Ages, such as smallpox. Mosier plans to address this possibility next.

The brief communication, "CCR5 mutation and protection against plague" was authored by Joan Mecsas, Greg Franklin,William A. Kuziel, Robert R. Brubaker, Stanley Falkow, and Donald E. Mosier and appears in the February 12, 2004 issue of the journal Nature.

This work was supported by the National Institutes of Health.

About The Scripps Research Institute

The Scripps Research Institute in La Jolla, California, is one of the world's largest, private, non-profit biomedical research organizations. It stands at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases and synthetic vaccine development.


Story Source:

The above story is based on materials provided by Scripps Research Institute. Note: Materials may be edited for content and length.


Cite This Page:

Scripps Research Institute. "Genetic Mutation Protects Against Both HIV And Plague? Not So, Say Scientists At Scripps Research." ScienceDaily. ScienceDaily, 12 February 2004. <www.sciencedaily.com/releases/2004/02/040212083108.htm>.
Scripps Research Institute. (2004, February 12). Genetic Mutation Protects Against Both HIV And Plague? Not So, Say Scientists At Scripps Research. ScienceDaily. Retrieved April 1, 2015 from www.sciencedaily.com/releases/2004/02/040212083108.htm
Scripps Research Institute. "Genetic Mutation Protects Against Both HIV And Plague? Not So, Say Scientists At Scripps Research." ScienceDaily. www.sciencedaily.com/releases/2004/02/040212083108.htm (accessed April 1, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, April 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

7-Year-Old Girl Gets 3-D Printed 'robohand'

7-Year-Old Girl Gets 3-D Printed 'robohand'

AP (Mar. 31, 2015) — Although she never had much interest in prosthetic limbs before, Faith Lennox couldn&apos;t wait to slip on her new robohand. The 7-year-old, who lost part of her left arm when she was a baby, grabbed it as soon as it came off a 3-D printer. (March 31) Video provided by AP
Powered by NewsLook.com
Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins